BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 6499929)

  • 1. Ketanserin alters [3H]serotonin uptake and release in rat hypothalamus.
    Offord SJ; Warwick RO
    Eur J Pharmacol; 1984 Sep; 104(3-4):379-82. PubMed ID: 6499929
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction between serotonin uptake inhibitors and alpha-2 adrenergic heteroreceptors in the rat hypothalamus.
    Blier P; Galzin AM; Langer SZ
    J Pharmacol Exp Ther; 1990 Jul; 254(1):236-44. PubMed ID: 2164092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. K+-evoked [3H]-5-HT release from rat frontal cortex slices: the effect of 5-HT agonists and antagonists.
    Mounsey I; Brady KA; Carroll J; Fisher R; Middlemiss DN
    Biochem Pharmacol; 1982 Jan; 31(1):49-53. PubMed ID: 7059349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of 5-HT release in the guinea-pig brain following long-term administration of antidepressant drugs.
    Blier P; Bouchard C
    Br J Pharmacol; 1994 Oct; 113(2):485-95. PubMed ID: 7834200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Panuramine, a selective inhibitor of uptake of 5-hydroxytryptamine in the brain of the rat.
    Blurton PA; Broadhurst AM; Cross JA; Ennis C; Wood MD; Wyllie MG
    Neuropharmacology; 1984 Sep; 23(9):1049-52. PubMed ID: 6514142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction between tricyclic and nontricyclic 5-hydroxytryptamine uptake inhibitors and the presynaptic 5-hydroxytryptamine inhibitory autoreceptors in the rat hypothalamus.
    Galzin AM; Moret C; Verzier B; Langer SZ
    J Pharmacol Exp Ther; 1985 Oct; 235(1):200-11. PubMed ID: 2864432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of pirenperone and ketanserin on rat prolactin secretion in vivo and in vitro.
    Meltzer HY; Simonovic M; Gudelsky GA
    Eur J Pharmacol; 1983 Aug; 92(1-2):83-9. PubMed ID: 6628538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of nonserotonergic [3H]ketanserin binding sites associated with nerve terminals in rat brain and with platelets; relation with release of biogenic amine metabolites induced by ketanserin- and tetrabenazine-like drugs.
    Leysen JE; Eens A; Gommeren W; van Gompel P; Wynants J; Janssen PA
    J Pharmacol Exp Ther; 1988 Jan; 244(1):310-21. PubMed ID: 3336007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antagonism of fenfluramine-induced hyperthermia in rats by some, but not all, selective inhibitors of 5-hydroxytryptamine uptake.
    Sugrue MF
    Br J Pharmacol; 1984 Apr; 81(4):651-7. PubMed ID: 6722394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. False labelling of dopaminergic terminals in the rabbit caudate nucleus: uptake and release of [3H]-5-hydroxytryptamine.
    Feuerstein TJ; Hertting G; Lupp A; Neufang B
    Br J Pharmacol; 1986 Jul; 88(3):677-84. PubMed ID: 3742155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo binding of [3H]ketanserin on serotonin S2-receptors in rat brain.
    Laduron PM; Janssen PF; Leysen JE
    Eur J Pharmacol; 1982 Jun; 81(1):43-8. PubMed ID: 7117369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of 5-HT2 receptors in rat cortex. Studies with a putative selective agonist and an antagonist.
    Pranzatelli MR
    Biochem Pharmacol; 1991 Aug; 42(5):1099-105. PubMed ID: 1872895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 5-HT3 receptors which modulate [3H]5-HT release in the guinea pig hypothalamus are not autoreceptors.
    Blier P; Monroe PJ; Bouchard C; Smith DL; Smith DJ
    Synapse; 1993 Oct; 15(2):143-8. PubMed ID: 7505063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of 5-HT3 receptors enhances the electrically evoked release of [3H]noradrenaline in rat brain limbic structures.
    Mongeau R; De Montigny C; Blier P
    Eur J Pharmacol; 1994 May; 256(3):269-79. PubMed ID: 8045271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estradiol-induced increase of specific [3H]ketanserin binding sites on rat uterine membranes.
    Ichida S; Hayashi T; Kita T; Murakami T
    Eur J Pharmacol; 1985 Feb; 108(3):257-64. PubMed ID: 3157585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo regulation of the serotonin-2 receptor in rat brain.
    Stockmeier CA; Kellar KJ
    Life Sci; 1986 Jan; 38(2):117-27. PubMed ID: 2935693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of serotonin release by bombesin-like peptides in rat hypothalamus in vitro.
    Saporito MS; Warwick RO
    Life Sci; 1989; 45(1):15-23. PubMed ID: 2545989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of serotonin antagonists in a behavioral despair procedure in mice.
    Luttinger D; Freedman M; Hamel L; Ward SJ; Perrone M
    Eur J Pharmacol; 1984 Dec; 107(1):53-8. PubMed ID: 6526071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selectivity of serotonergic drugs for multiple brain serotonin receptors. Role of [3H]-4-bromo-2,5-dimethoxyphenylisopropylamine ([3H]DOB), a 5-HT2 agonist radioligand.
    Titeler M; Lyon RA; Davis KH; Glennon RA
    Biochem Pharmacol; 1987 Oct; 36(19):3265-71. PubMed ID: 3663239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional characterization of a 5-HT3 receptor which modulates the release of 5-HT in the guinea-pig brain.
    Blier P; Bouchard C
    Br J Pharmacol; 1993 Jan; 108(1):13-22. PubMed ID: 8428202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.